GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with limited treatment options, underscoring the need for novel therapeutic targets. Metabolic reprogramming is a hallmark of PDAC, enabling tumor cells to sustain rapid proliferation and survive ... ...
